Green Cross Health Ltd
NZX:GXH
Intrinsic Value
Green Cross Health Ltd. engages in the provision of healthcare solutions. [ Read More ]
The intrinsic value of one
GXH
stock under the Base Case scenario is
2.59
NZD.
Compared to the current market price of 1 NZD,
Green Cross Health Ltd
is
Undervalued by 61%.
GXH could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
Green Cross Health Ltd's market capitalization is 143.5m NZD.
GXH stock price is 1 NZD.
GXH stock price (1 NZD) is 61% less than its Intrinsic Value (2.59 NZD).
GXH has upside potential of 120% compared to the average analyst price target.
Open Wall St Estimates
GXH's ROIC (Return on Invested Capital) has increased in the last 3 years from 10% to 11%.
GXH's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 11%.
GXH's Revenue has grown by 2% over the past 12 months.
GXH has positive three-year average ROIC (Return on Invested Capital): 11%. The company is efficient at using invested capital to generate operating income.
GXH has positive Operating Income for the last twelve months.
GXH has positive Net Income for the last twelve months.
GXH's Revenue has been growing by 9% per year for the last 3 years.
GXH's short-term liabilties (93m NZD) exceed its short-term assets (82m NZD).
GXH has positive Free Cash Flow for the last twelve months.
GXH's D/E (Debt to Equity) is very low and is equal to 0.78.
GXH has positive three-year average ROE (Return on Equity): 19%. The company is efficient at transforming stockholders' equity into net income.
GXH's long-term assets (375m NZD) exceed its long-term liabilties (223m NZD).
GXH's ROE (Return on Equity) for the past 12 months is very high and is equal to 32%.
GXH's ROE (Return on Equity) has significantly increased in the last 3 years from 13% to 32%.
GXH's Altman Z-Score is very high and is equal to 3.01.
GXH has positive Gross Profit for the last twelve months.
GXH has positive Net Debt. This means that the company has more debt (119m NZD) than cash and short-term investments (18m NZD).
Valuation Backtest
Green Cross Health Ltd
Run backtest to discover the historical profit from buying and selling
GXH
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Green Cross Health Ltd
Balance Sheet Decomposition
Green Cross Health Ltd
| Current Assets | 82m |
| Cash & Short-Term Investments | 18.5m |
| Receivables | 30.8m |
| Other Current Assets | 32.8m |
| Non-Current Assets | 292.9m |
| Long-Term Investments | 6.8m |
| PP&E | 111.8m |
| Intangibles | 159.8m |
| Other Non-Current Assets | 14.5m |
| Current Liabilities | 93.2m |
| Accounts Payable | 32.7m |
| Accrued Liabilities | 32.2m |
| Other Current Liabilities | 28.3m |
| Non-Current Liabilities | 129.9m |
| Long-Term Debt | 119.1m |
| Other Non-Current Liabilities | 10.7m |
Earnings Waterfall
Green Cross Health Ltd
|
Revenue
|
743.8m
NZD
|
|
Cost of Revenue
|
-318.6m
NZD
|
|
Gross Profit
|
425.2m
NZD
|
|
Operating Expenses
|
-378m
NZD
|
|
Operating Income
|
47.2m
NZD
|
|
Other Expenses
|
3.6m
NZD
|
|
Net Income
|
50.8m
NZD
|
Free Cash Flow Analysis
Green Cross Health Ltd
GXH Profitability Score
Profitability Due Diligence
Green Cross Health Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Green Cross Health Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
GXH Solvency Score
Solvency Due Diligence
Green Cross Health Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Green Cross Health Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GXH Price Targets Summary
Green Cross Health Ltd
According to Wall Street analysts, the average 1-year price target for
GXH
is 2.2 NZD
.
Shareholder Return
GXH Price
Green Cross Health Ltd
| Average Annual Return | 9.71% |
| Standard Deviation of Annual Returns | 12.41% |
| Max Drawdown | -42% |
| Market Capitalization | 140.6m NZD |
| Shares Outstanding | 143 461 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Green Cross Health Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Green Cross Health Ltd. engages in the provision of healthcare solutions. The firm supports a range of ancillary services, such as radiology, physiotherapy, midwives and social workers. The firm operates in three segments: Pharmacy services, Medical services and Community Health. The firm's operations are in the pharmacy industry providing pharmacy services through consolidated stores, equity accounted investments and franchise stores. The Medical services segment includes equity accounted medical centers, and support services provided to the medical centers, as well as medical centers outside the Company. The Community Health segment provides services direct to the community to support independent living. The firm's medical network provides general practice services across New Zealand with over 900 doctors, nurses and healthcare practitioners. The firm operates under various brands, such as Unichem, Life Pharmacy, Access and The Doctors.
Contact
IPO
Employees
Officers
The intrinsic value of one
GXH
stock under the Base Case scenario is
2.59
NZD.
Compared to the current market price of 1 NZD,
Green Cross Health Ltd
is
Undervalued by 61%.
You don't have any saved screeners yet
